{"organizations": [], "uuid": "a7f807997cbb13c1acebe7a9ce77758ba5580c3d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-opgen-says-entered-agreement-to-us/brief-opgen-says-entered-agreement-to-use-thermo-fishers-real-time-pcr-technology-in-cos-new-acuitas-tests-idUSFWN1Q30YS", "country": "US", "domain_rank": 408, "title": "OpGen Says ‍Entered Agreement To Use Thermo Fisher's Real-Time PCR Technology In Co's New Acuitas Tests​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-13T20:39:00.000+02:00", "replies_count": 0, "uuid": "a7f807997cbb13c1acebe7a9ce77758ba5580c3d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-opgen-says-entered-agreement-to-us/brief-opgen-says-entered-agreement-to-use-thermo-fishers-real-time-pcr-technology-in-cos-new-acuitas-tests-idUSFWN1Q30YS", "ord_in_thread": 0, "title": "OpGen Says ‍Entered Agreement To Use Thermo Fisher's Real-Time PCR Technology In Co's New Acuitas Tests​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "opgen inc", "sentiment": "negative"}, {"name": "real-time pcr technology in co", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Opgen Inc:\n* OPGEN INC - ‍ENTERED GLOBAL SUPPLY AGREEMENT TO USE THERMO FISHER SCIENTIFIC‘S REAL-TIME PCR TECHNOLOGY IN COMPANY‘S ACUITAS AMR GENE PANEL TESTS​\n* OPGEN INC - ‍PLANNING CLINICAL TRIALS TO SUPPORT REGULATORY SUBMISSIONS FOR BROADER CLINICAL USE IN PATIENTS WITH COMPLICATED URINARY TRACT INFECTIONS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-13T20:39:00.000+02:00", "crawled": "2018-02-14T12:37:39.016+02:00", "highlightTitle": ""}